HONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters. China's medical products regulator – the National Medical Products Administration (NMPA) – has been leading the talks with Pfizer since...
HONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters.
Chinese hospitals are under intense pressure after the government abruptly abandoned its "zero-Covid" policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm. In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.
The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.Prospective candidates including Huahai and CSPC have in recent weeks been conducting "bioequivalence tests", which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
China in talks with Pfizer for generic Covid-19 drug: SourcesBeijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan 22. Read more at straitstimes.com.
続きを読む »
The US keeps offering China its Covid-19 vaccines, but China keeps saying noBeijing has repeatedly said it has enough vaccines. Read more at straitstimes.com.
続きを読む »
China Evergrande to hold talks with bondholders on Wednesday -sourcesHONG KONG : Embattled property developer China Evergrande Group will hold a meeting with dollar bondholders on Wednesday to discuss its debt restructuring proposals, two sources familiar with the matter said on Friday.Once China's top-selling developer, Evergrande is now at the centre of the country's pr
続きを読む »
Biden raises concern over China's COVID-19 response after WHO questions dataBEIJING: United States President Joe Biden raised concern about China's handling of its COVID-19 outbreak hours after the World Health Organization (WHO) said that China was underreporting deaths
続きを読む »
German expats in China receive first foreign Covid-19 vaccinesGermans in China can now receive the BioNTech vaccine at a hospitals in Beijing, Shanghai, Shenyang, Guangzhou and Chengdu. Read more at straitstimes.com.
続きを読む »
China urges WHO to take 'just position' on Covid-19 after data criticismBeijing insists it has always 'shared relevant information and data with the international community”. Read more at straitstimes.com.
続きを読む »